Treatment‐emergent hypertension and efficacy in the phase 3 Study of (E7080) lenvatinib in differentiated cancer of the thyroid (SELECT)
Wirth, Lori J., Tahara, Makoto, Robinson, Bruce, Francis, Sanjeev, Brose, Marcia S., Habra, Mouhammed Amir, Newbold, Kate, Kiyota, Naomi, Dutcus, Corina E., Mathias, Elton, Guo, Matthew, Sherman, Steven I., Schlumberger, Martin
Published in Cancer (01.06.2018)
Published in Cancer (01.06.2018)
Get full text
Journal Article
Characterization of Tumor Size Changes Over Time From the Phase 3 Study of Lenvatinib in Thyroid Cancer
Robinson, Bruce, Schlumberger, Martin, Wirth, Lori J, Dutcus, Corina E, Song, James, Taylor, Matthew H, Kim, Sung-Bae, Krzyzanowska, Monika K, Capdevila, Jaume, Sherman, Steven I, Tahara, Makoto
Published in The journal of clinical endocrinology and metabolism (01.11.2016)
Published in The journal of clinical endocrinology and metabolism (01.11.2016)
Get full text
Journal Article
Urine protein:creatinine ratio vs 24-hour urine protein for proteinuria management: analysis from the phase 3 REFLECT study of lenvatinib vs sorafenib in hepatocellular carcinoma
Evans, Thomas R. Jeffry, Kudo, Masatoshi, Finn, Richard S., Han, Kwang-Hyub, Cheng, Ann-Lii, Ikeda, Masafumi, Kraljevic, Silvija, Ren, Min, Dutcus, Corina E., Piscaglia, Fabio, Sung, Max W.
Published in British journal of cancer (30.07.2019)
Published in British journal of cancer (30.07.2019)
Get full text
Journal Article
Correction: Urine protein:creatinine ratio vs 24-hour urine protein for proteinuria management: analysis from the phase 3 REFLECT study of lenvatinib vs sorafenib in hepatocellular carcinoma
Evans, Thomas R. Jeffry, Kudo, Masatoshi, Finn, Richard S., Han, Kwang-Hyub, Cheng, Ann-Lii, Ikeda, Masafumi, Kraljevic, Silvija, Ren, Min, Dutcus, Corina E., Piscaglia, Fabio, Sung, Max W.
Published in British journal of cancer (30.07.2019)
Published in British journal of cancer (30.07.2019)
Get full text
Journal Article
Subgroup Analyses from a Phase 3, Open-Label, Randomized Study of Eribulin Mesylate Versus Capecitabine in Pretreated Patients with Advanced or Metastatic Breast Cancer
Twelves, Chris, Awada, Ahmad, Cortes, Javier, Yelle, Louise, Velikova, Galina, Olivo, Martin S., Song, James, Dutcus, Corina E., Kaufman, Peter A.
Published in Breast cancer : basic and clinical research (01.01.2016)
Published in Breast cancer : basic and clinical research (01.01.2016)
Get full text
Journal Article
Lenvatinib Plus Pembrolizumab in Patients With Advanced Endometrial Cancer
Makker, Vicky, Taylor, Matthew H, Aghajanian, Carol, Oaknin, Ana, Mier, James, Cohn, Allen L, Romeo, Margarita, Bratos, Raquel, Brose, Marcia S, DiSimone, Christopher, Messing, Mark, Stepan, Daniel E, Dutcus, Corina E, Wu, Jane, Schmidt, Emmett V, Orlowski, Robert, Sachdev, Pallavi, Shumaker, Robert, Casado Herraez, Antonio
Published in Journal of clinical oncology (10.09.2020)
Published in Journal of clinical oncology (10.09.2020)
Get full text
Journal Article
Phase Ib Study of Lenvatinib Plus Pembrolizumab in Patients With Unresectable Hepatocellular Carcinoma
Finn, Richard S, Ikeda, Masafumi, Zhu, Andrew X, Sung, Max W, Baron, Ari D, Kudo, Masatoshi, Okusaka, Takuji, Kobayashi, Masahiro, Kumada, Hiromitsu, Kaneko, Shuichi, Pracht, Marc, Mamontov, Konstantin, Meyer, Tim, Kubota, Tomoki, Dutcus, Corina E, Saito, Kenichi, Siegel, Abby B, Dubrovsky, Leonid, Mody, Kalgi, Llovet, Josep M
Published in Journal of clinical oncology (10.09.2020)
Published in Journal of clinical oncology (10.09.2020)
Get full text
Journal Article
Phase IB/II Trial of Lenvatinib Plus Pembrolizumab in Patients With Advanced Renal Cell Carcinoma, Endometrial Cancer, and Other Selected Advanced Solid Tumors
Taylor, Matthew H, Lee, Chung-Han, Makker, Vicky, Rasco, Drew, Dutcus, Corina E, Wu, Jane, Stepan, Daniel E, Shumaker, Robert C, Motzer, Robert J
Published in Journal of clinical oncology (10.04.2020)
Published in Journal of clinical oncology (10.04.2020)
Get full text
Journal Article
Phase III open-label randomized study of eribulin mesylate versus capecitabine in patients with locally advanced or metastatic breast cancer previously treated with an anthracycline and a taxane
Kaufman, Peter A, Awada, Ahmad, Twelves, Chris, Yelle, Louise, Perez, Edith A, Velikova, Galina, Olivo, Martin S, He, Yi, Dutcus, Corina E, Cortes, Javier
Published in Journal of clinical oncology (20.02.2015)
Published in Journal of clinical oncology (20.02.2015)
Get full text
Journal Article
Prolonged duration of response in lenvatinib responders with thyroid cancer
Gianoukakis, Andrew G, Dutcus, Corina E, Batty, Nicolas, Guo, Matthew, Baig, Mahadi
Published in Endocrine-related cancer (01.06.2018)
Published in Endocrine-related cancer (01.06.2018)
Get full text
Journal Article
A Phase Ib/II Study of Lenvatinib and Pembrolizumab in Advanced Endometrial Carcinoma (Study 111/KEYNOTE-146): Long-Term Efficacy and Safety Update
Makker, Vicky, Aghajanian, Carol, Cohn, Allen L, Romeo, Margarita, Bratos, Raquel, Brose, Marcia S, Messing, Mark, Dutta, Lea, Dutcus, Corina E, Huang, Jie, Schmidt, Emmett V, Orlowski, Robert, Taylor, Matthew H
Published in Journal of clinical oncology (10.02.2023)
Published in Journal of clinical oncology (10.02.2023)
Get full text
Journal Article
Pharmacodynamic Biomarkers Predictive of Survival Benefit with Lenvatinib in Unresectable Hepatocellular Carcinoma: From the Phase III REFLECT Study
Finn, Richard S, Kudo, Masatoshi, Cheng, Ann-Lii, Wyrwicz, Lucjan, Ngan, Roger K C, Blanc, Jean-Frederic, Baron, Ari D, Vogel, Arndt, Ikeda, Masafumi, Piscaglia, Fabio, Han, Kwang-Hyub, Qin, Shukui, Minoshima, Yukinori, Kanekiyo, Michio, Ren, Min, Dairiki, Ryo, Tamai, Toshiyuki, Dutcus, Corina E, Ikezawa, Hiroki, Funahashi, Yasuhiro, Evans, Thomas R Jeffry
Published in Clinical cancer research (01.09.2021)
Published in Clinical cancer research (01.09.2021)
Get full text
Journal Article
Lenvatinib for Anaplastic Thyroid Cancer
Tahara, Makoto, Kiyota, Naomi, Yamazaki, Tomoko, Chayahara, Naoko, Nakano, Kenji, Inagaki, Lina, Toda, Kazuhisa, Enokida, Tomohiro, Minami, Hironobu, Imamura, Yoshinori, Sasaki, Tatsuya, Suzuki, Takuya, Fujino, Katsuki, Dutcus, Corina E, Takahashi, Shunji
Published in Frontiers in oncology (01.03.2017)
Published in Frontiers in oncology (01.03.2017)
Get full text
Journal Article
Correlative serum biomarker analyses in the phase 2 trial of lenvatinib-plus-everolimus in patients with metastatic renal cell carcinoma
Lee, Chung-Han, Motzer, Robert J., Glen, Hilary, Michaelson, M. D., Larkin, James, Minoshima, Yukinori, Kanekiyo, Michio, Ikezawa, Hiroki, Sachdev, Pallavi, Dutcus, Corina E., Funahashi, Yasuhiro, Voss, Martin H.
Published in British journal of cancer (05.01.2021)
Published in British journal of cancer (05.01.2021)
Get full text
Journal Article
Safety, pharmacokinetics, and preliminary efficacy of E6201 in patients with advanced solid tumours, including melanoma: results of a phase 1 study
Tibes, Raoul, Borad, Mitesh J., Dutcus, Corina E., Reyderman, Larisa, Feit, Kevie, Eisen, Andrew, Verbel, David A., Von Hoff, Daniel D.
Published in British journal of cancer (01.06.2018)
Published in British journal of cancer (01.06.2018)
Get full text
Journal Article
Eribulin Monotherapy in Patients Aged 70 Years and Older With Metastatic Breast Cancer
Muss, Hyman, Cortes, Javier, Vahdat, Linda T., Cardoso, Fatima, Twelves, Chris, Wanders, Jantien, Dutcus, Corina E., Yang, Jay, Seegobin, Seth, O'Shaughnessy, Joyce
Published in The oncologist (Dayton, Ohio) (01.04.2014)
Published in The oncologist (Dayton, Ohio) (01.04.2014)
Get full text
Journal Article
A phase Ib study of lenvatinib (LEN) plus nivolumab (NIV) in patients (pts) with unresectable hepatocellular carcinoma (uHCC): Study 117
Kudo, Masatoshi, Ikeda, Masafumi, Motomura, Kenta, Okusaka, Takuji, Kato, Naoya, Dutcus, Corina E., Hisai, Takashi, Suzuki, Mayumi, Ikezawa, Hiroki, Iwata, Takeyuki, Kumada, Hiromitsu, Kobayashi, Masahiro
Published in Journal of clinical oncology (01.02.2020)
Published in Journal of clinical oncology (01.02.2020)
Get full text
Journal Article
A phase 3 trial evaluating efficacy and safety of lenvatinib in combination with pembrolizumab in patients with advanced endometrial cancer
Makker, Vicky, Casado Herraez, Antonio, Aghajanian, Carol, Fujiwara, Keiichi, Pignata, Sandro, Penson, Richard T., Dutcus, Corina E., Guo, Matthew, Dutta, Lea, Orlowski, Robert, Smith, Alan, Miller, David S.
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article
Association between biomarkers and clinical outcomes of lenvatinib + pembrolizumab in advanced renal cell carcinoma (RCC): Results from Study 111/KEYNOTE-146
Lee, Chung-Han, Rasco, Drew W., Rao, Arpit, Taylor, Matthew H., Hsieh, James J, Pinto, Alvaro, Vogelzang, Nicholas J., Cao, Z. Alexander, Suttner, Leah, Loboda, Andrey, Vajdi, Amir, Predoiu, Raluca Andreia, Nebozhyn, Michael, Lunceford, Jared, Perini, Rodolfo F., Matsui, Junji, Minoshima, Yukinori, Dutcus, Corina E., Dutta, Lea, Motzer, Robert J.
Published in Journal of clinical oncology (20.02.2022)
Published in Journal of clinical oncology (20.02.2022)
Get full text
Journal Article
Phase Ib/II trial of lenvatinib plus pembrolizumab in advanced melanoma
Taylor, Matthew H., Vogelzang, Nicholas J., Cohn, Allen Lee, Stepan, Daniel E., Shumaker, Robert Charles, Dutcus, Corina E., Guo, Matthew, Schmidt, Emmett V., Rasco, Drew W.
Published in Journal of clinical oncology (10.03.2019)
Published in Journal of clinical oncology (10.03.2019)
Get full text
Journal Article